CME Group (CME)
(Real Time Quote from BATS)
$216.93 USD
-1.23 (-0.56%)
Updated Sep 25, 2024 11:42 AM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for CME Group Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 3,226.20 | 2,691.00 | 2,636.90 | 2,106.40 | 2,115.80 |
Depreciation/Amortization & Depletion | 352.60 | 362.60 | 385.40 | 464.40 | 473.30 |
Net Change from Assets/Liabilities | -60.80 | -95.20 | -161.80 | 67.80 | -22.70 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -64.20 | 97.60 | -458.10 | 77.00 | 106.40 |
Net Cash From Operating Activities | 3,453.80 | 3,056.00 | 2,402.40 | 2,715.60 | 2,672.80 |
Property & Equipment | -76.40 | -89.70 | -87.90 | -197.50 | -245.60 |
Acquisition/ Disposition of Subsidiaries | 97.90 | 11.10 | 48.50 | 26.30 | 89.60 |
Investments | -0.60 | -411.20 | -2.90 | -4.30 | 3.40 |
Other Investing Activities | 0.00 | 0.00 | 100.70 | 0.00 | 0.00 |
Net Cash from Investing Activities | 20.90 | -489.80 | 58.40 | -175.50 | -152.60 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 965.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 741.00 | 0.00 | 0.00 | -92.50 |
Increase (Decrease) Short-Term Debt | -16.40 | -756.20 | 0.00 | -304.60 | -569.20 |
Payment of Dividends & Other Distributions | -3,235.50 | -2,633.50 | -2,189.30 | -2,110.00 | -1,695.90 |
Other Financing Activities | -45,087.40 | -22,733.00 | 71,133.00 | -43.60 | 16.80 |
Net Cash from Financing Activities | -48,339.30 | -25,381.70 | 69,908.70 | -2,458.20 | -2,340.80 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -44,864.60 | -22,815.50 | 72,369.50 | 81.90 | 179.40 |
Cash at Beginning of Period | 137,974.30 | 160,789.80 | 88,420.30 | 1,556.60 | 1,377.20 |
Cash at End of Period | 93,109.70 | 137,974.30 | 160,789.80 | 1,638.50 | 1,556.60 |
Diluted Net EPS | 8.86 | 7.40 | 7.29 | 5.87 | 5.91 |
Fiscal Year End for CME Group Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 1,738.40 | 855.20 | 3,226.20 | 2,411.60 | 1,661.40 |
Depreciation/Amortization & Depletion | 169.50 | 85.30 | 352.60 | 266.30 | 178.00 |
Net Change from Assets/Liabilities | -236.60 | -64.80 | -60.80 | -229.40 | -241.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -1.70 | 17.00 | -64.20 | -39.00 | -45.60 |
Net Cash From Operating Activities | 1,669.60 | 892.70 | 3,453.80 | 2,409.50 | 1,552.80 |
Property & Equipment | -38.00 | -19.80 | -76.40 | -55.60 | -35.70 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 97.90 | 0.00 | 0.00 |
Investments | 10.20 | -3.00 | -0.60 | 96.90 | 96.50 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -27.80 | -22.80 | 20.90 | 41.30 | 60.80 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | -16.40 | -16.40 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | -16.40 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -2,746.90 | -2,328.40 | -3,235.50 | -2,835.40 | -2,435.40 |
Other Financing Activities | -4,539.50 | 4,264.80 | -45,087.40 | -48,076.00 | -22,009.20 |
Net Cash from Financing Activities | -7,286.40 | 1,936.40 | -48,339.30 | -50,927.80 | -24,461.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -5,644.60 | 2,806.30 | -44,864.60 | -48,477.00 | -22,847.40 |
Cash at Beginning of Period | 93,109.70 | 93,109.70 | 137,974.30 | 137,974.40 | 137,974.30 |
Cash at End of Period | 87,465.10 | 95,916.00 | 93,109.70 | 89,497.40 | 115,126.90 |
Diluted Net EPS | 2.42 | 2.35 | 2.23 | 2.06 | 2.14 |